Found 2 hits Enz. Inhib. hit(s) with Target = 'Integrin alpha-IIb/beta-3' and Ligand = 'BDBM50010167' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50010167
(1N-[1-[5-amino-1-formyl-(1S)-pentylcarbamoyl]-(1S)...)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1cnc[nH]1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O Show InChI InChI=1S/C52H82N18O17/c1-25(2)14-34(68-50(84)36(16-31-19-56-24-61-31)69-49(83)35(64-29(7)71)15-30-18-55-23-60-30)46(80)59-20-39(73)57-21-40(74)62-28(6)45(79)66-32(10-8-9-13-53)48(82)67-33(11-12-38(54)72)47(81)63-27(5)44(78)58-22-41(75)65-37(17-42(76)77)51(85)70-43(26(3)4)52(86)87/h18-19,23-28,32-37,43H,8-17,20-22,53H2,1-7H3,(H2,54,72)(H,55,60)(H,56,61)(H,57,73)(H,58,78)(H,59,80)(H,62,74)(H,63,81)(H,64,71)(H,65,75)(H,66,79)(H,67,82)(H,68,84)(H,69,83)(H,70,85)(H,76,77)(H,86,87)/t27-,28-,32-,33-,34-,35-,36-,37-,43-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| 1.45E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
| Assay Description
Inhibition of canine platelet-rich plasma agregation induced by ADP |
J Med Chem 34: 3114-25 (1991)
BindingDB Entry DOI: 10.7270/Q2445KF0 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50010167
(1N-[1-[5-amino-1-formyl-(1S)-pentylcarbamoyl]-(1S)...)Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1cnc[nH]1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O Show InChI InChI=1S/C52H82N18O17/c1-25(2)14-34(68-50(84)36(16-31-19-56-24-61-31)69-49(83)35(64-29(7)71)15-30-18-55-23-60-30)46(80)59-20-39(73)57-21-40(74)62-28(6)45(79)66-32(10-8-9-13-53)48(82)67-33(11-12-38(54)72)47(81)63-27(5)44(78)58-22-41(75)65-37(17-42(76)77)51(85)70-43(26(3)4)52(86)87/h18-19,23-28,32-37,43H,8-17,20-22,53H2,1-7H3,(H2,54,72)(H,55,60)(H,56,61)(H,57,73)(H,58,78)(H,59,80)(H,62,74)(H,63,81)(H,64,71)(H,65,75)(H,66,79)(H,67,82)(H,68,84)(H,69,83)(H,70,85)(H,76,77)(H,86,87)/t27-,28-,32-,33-,34-,35-,36-,37-,43-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| n/a | n/a | >2.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Research and Development
Curated by ChEMBL
| Assay Description
Inhibition of canine platelet-rich plasma agregation induced by ADP |
J Med Chem 34: 3114-25 (1991)
BindingDB Entry DOI: 10.7270/Q2445KF0 |
More data for this
Ligand-Target Pair | |
Search and Browse
